These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A second locus for Schneckenbecken dysplasia identified by a mutation in the gene encoding inositol polyphosphate phosphatase-like 1 (INPPL1). Lee H; Nevarez L; Lachman RS; Wilcox WR; Krakow D; Cohn DH; Am J Med Genet A; 2015 Oct; 167A(10):2470-3. PubMed ID: 25997753 [No Abstract] [Full Text] [Related]
6. Opsismodysplasia resulting from an insertion mutation in the SH2 domain, which destabilizes INPPL1. Li B; Krakow D; Nickerson DA; Bamshad MJ; ; Chang Y; Lachman RS; Yilmaz A; Kayserili H; Cohn DH Am J Med Genet A; 2014 Sep; 164A(9):2407-11. PubMed ID: 24953221 [No Abstract] [Full Text] [Related]
7. Novel compound heterozygous mutations in inositol polyphosphate phosphatase-like 1 in a family with severe opsismodysplasia. Feist C; Holden P; Fitzgerald J Clin Dysmorphol; 2016 Oct; 25(4):152-5. PubMed ID: 27233067 [TBL] [Abstract][Full Text] [Related]
8. Genetic association analysis of inositol polyphosphate phosphatase-like 1 (INPPL1, SHIP2) variants with essential hypertension. Marçano AC; Burke B; Gungadoo J; Wallace C; Kaisaki PJ; Woon PY; Farrall M; Clayton D; Brown M; Dominiczak A; Connell JM; Webster J; Lathrop M; Caulfield M; Samani N; Gauguier D; Munroe PB J Med Genet; 2007 Sep; 44(9):603-5. PubMed ID: 17557929 [TBL] [Abstract][Full Text] [Related]
9. Altered chondrocyte differentiation, matrix mineralization and MEK-Erk1/2 signaling in an INPPL1 catalytic knock-out mouse model of opsismodysplasia. Vande Catsyne CA; Sayyed SA; Molina-Ortiz P; Moes B; Communi D; Muller J; Heusschen R; Caers J; Azzi A; Erneux C; Schurmans S Adv Biol Regul; 2020 May; 76():100651. PubMed ID: 31519471 [TBL] [Abstract][Full Text] [Related]
10. Opsismodysplasia: Phosphate Wasting Osteodystrophy Responds to Bisphosphonate Therapy. Khwaja A; Parnell SE; Ness K; Bompadre V; White KK Front Pediatr; 2015; 3():48. PubMed ID: 26157786 [TBL] [Abstract][Full Text] [Related]
11. Fibroblasts derived from patients with opsismodysplasia display SHIP2-specific cell migration and adhesion defects. Ghosh S; Huber C; Siour Q; Sousa SB; Wright M; Cormier-Daire V; Erneux C Hum Mutat; 2017 Dec; 38(12):1731-1739. PubMed ID: 28869677 [TBL] [Abstract][Full Text] [Related]
12. The diversity and possible functions of the inositol polyphosphate 5-phosphatases. Erneux C; Govaerts C; Communi D; Pesesse X Biochim Biophys Acta; 1998 Dec; 1436(1-2):185-99. PubMed ID: 9838104 [TBL] [Abstract][Full Text] [Related]
13. Phosphoinositide phosphatases: just as important as the kinases. Dyson JM; Fedele CG; Davies EM; Becanovic J; Mitchell CA Subcell Biochem; 2012; 58():215-79. PubMed ID: 22403078 [TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in type II SH2 domain-containing inositol 5-phosphatase (INPPL1, SHIP2) are associated with physiological abnormalities of the metabolic syndrome. Kaisaki PJ; Delépine M; Woon PY; Sebag-Montefiore L; Wilder SP; Menzel S; Vionnet N; Marion E; Riveline JP; Charpentier G; Schurmans S; Levy JC; Lathrop M; Farrall M; Gauguier D Diabetes; 2004 Jul; 53(7):1900-4. PubMed ID: 15220217 [TBL] [Abstract][Full Text] [Related]